Glycomet 250 mg is a member of a class of anti-diabetic medications known as biguanides that is used to treat diabetes. It contributes to the reduction of elevated blood glucose levels in type 2 diabetic patients. Type 2 diabetes is a chronic or lifelong disease that impairs our body’s glucose metabolism. Individuals with type 2 diabetes either produce insufficient insulin or the insulin produced is unable to work properly in the body (insulin resistance). Type 2 diabetes is most commonly found in middle-aged or older adults, which is why it is also referred to as adult-onset diabetes.
Glycomet 250 mg is administered to patients with type 2 diabetes who are unable to control their blood sugar levels by diet and exercise alone. It is the first-line therapy for type 2 diabetic patients. Glycomet 250 mg normalizes the body’s insulin response, reduces the quantity of blood sugar produced by the liver, and delays sugar absorption by the stomach or intestines. Additionally, Glycomet 250 mg is used off-label in women with polycystic ovarian syndrome (PCOS) to assist restore the menstrual cycle by reestablishing hormonal balance in the body, lowering blood sugar levels, and stimulating ovulation.